Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    22048171 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs
Condition: Infections, Papillomavirus
Interventions: Biological: Cervarix;   Drug: Placebo
2 Not yet recruiting Evaluation of Long Term Immunity Following HPV Vaccination
Conditions: Cervical Cancer;   Anogenital Warts
Intervention: Biological: Cervarix®

Indicates status has not been verified in more than two years